Patents by Inventor Michael Breindl

Michael Breindl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240183981
    Abstract: An optoelectronic sensor for the detection and distance determination of objects in a monitored zone has a light transmitter for transmitting a transmitted pulse, a deflection unit for transmitting the transmitted pulses in different angular positions, a light receiver for generating a received signal, and a control and evaluation unit configured to recognize a received pulse that the transmitted pulse remitted or reflected in the monitored zone generates in the received signal, and to measure a distance between the transmission of the transmitted pulse and the reception of the received pulse with reference to a time of flight, as well as to recognize the presence of fog by evaluating the received signal. The control and evaluation unit is furthermore configured to recognize the presence of fog by checking a time portion of the received signal with a fog signature corresponding to the received pulse.
    Type: Application
    Filed: December 1, 2023
    Publication date: June 6, 2024
    Inventors: Patrick STEIN, Christiane FILLHARDT, Markus HAMMES, Joachim KRÄMER, Michael BREINDL
  • Publication number: 20030088883
    Abstract: The present invention relates to the use of a reporter gene to study the tissue-specific expression of certain genes associated with fibrotic disease. More particularly, it relates to transgenic nucleic acid constructs having the reporter gene under operational control of the Colla1 promoter further comprising a regulatory element that regulates the expression of collagen. Such constructs and methods using these constructs are particularly useful in studying correct stage and tissue specific expression of collagen.
    Type: Application
    Filed: November 27, 2002
    Publication date: May 8, 2003
    Inventors: Michael Breindl, David A. Brenner
  • Publication number: 20020120946
    Abstract: The present invention relates to the use of a reporter gene to study the tissue-specific expression of certain genes associated with fibrotic disease. More particularly, it relates to transgenic nucleic acid constructs having the reporter gene under operational control of the Collal promoter further comprising a regulatory element that regulates the expression of collagen. Such constructs and methods using these constructs are particularly useful in studying correct stage and tissue specific expression of collagen.
    Type: Application
    Filed: December 22, 2000
    Publication date: August 29, 2002
    Inventors: Michael Breindl, David A. Brenner